Business
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PZZA, TGTX, MGTI, CHGG and GOOG
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of PZZA, TGTX, MGTI, CHGG and GOOG.
About this update from Mgt Capital Investments, Inc.
[{"type":"text","content":"\nNEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.        \n Papa John’s International, Inc. (NASDAQ: PZZA) Class Period: February 25, 2014 to July 19, 2018 Lead Plaintiff Deadline: October 29, 2018 Papa John’s International, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Papa John’s executives, including Defendant John H. Schnatter, had engaged in a pattern of sexual harassment and other inappropriate workplace conduct at the Company; (ii) Papa John’s Code of Ethics and Business Conduct was inadequate to prevent the foregoing misconduct; (iii) the foregoing conduct would foreseeably have a negative impact on Papa John’s business and operations, and expose Papa John’s to reputational harm, heightened regulatory scrutiny, and legal liability; and (iv) as a result, Papa John’s public statements were materially false and misleading at all relevant times. Get additional information about the PZZA lawsuit: http://www.kleinstocklaw.com/pslra-1/papa-johns-international-inc-loss-form?wire=3 TG Therapeutics, Inc. (NASDAQCM: TGTX) Class Period: June 4, 2018 to September 25, 2018 Lead Plaintiff Deadline: December 3, 2018 The lawsuit alleges TG Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) TG was involved in cleaning the data collected in the UNITY-CLL Trial; and as a result, was able to gain an understanding as to the efficacy of the combination therapy; (2) as a result of that data cleaning, TG knew the UNITY-CLL Trial had failed to meet its stated goal and as a result, the Company would not be able to seek accelerated approval; and (3) given that the UNITY-CLL Trial had failed to meet its stated goal, it was highly unlikely that the combination therapy would meet its primary endpoint of increased progression free survival. Get additional information about the TGTX lawsuit: http://www.kleinstocklaw.com/pslra-1/tg-therapeutics-inc-loss-submission-form?wire=3 MGT Capital Investments Inc. (OTCMKTS:...